Respiratory Virus Hospitalization Study (FLU 003 Plus)

Completed

Conditions studied: Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

In brief

Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus, this observational study was initiated to estimate rates of morbidity and mortality and to examine predictors of severity among participants with 2009 H1N1 infection. In 2011, as surveillance indicated that 2009 H1N1 virus was co-circulating with other seasonal influenza A and B viruses worldwide, the protocol was expanded to include other influenza A subtypes and influenza B viruses. The current version of the protocol (released in August 2013) further broadens the scope of this observational study. With the recognition that novel respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public health importance, the objectives of this protocol have been expanded.

Key facts

Study ID

NCT01056185

Run by

University of Minnesota

People needed

1000

Starts

2009-08-01

Expected to finish

2024-08-30

Last updated by the study team

2024-10-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be ≥ 18 years of age
• Have been admitted to hospital
• Have a signed informed consent by participant or surrogate/representative
• Have a local diagnosis (confirmed or suspected) of influenza, or of a targeted non-influenza viral respiratory infection*, resulting in (or extending a previous) hospitalization
• A list of targeted non-influenza respiratory viruses is maintained on the INSIGHT website.

You may not qualify if…

• Current imprisonment, or compulsory detention (involuntary incarceration) for treat of a psychiatric or physical illness.

Where it is running

• George Washington Medical Faculty Associates — Washington D.C., District of Columbia, United States
• Washington DC VA Medical Center — Washington D.C., District of Columbia, United States
• University of Illinois at Chicago — Chicago, Illinois, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Baystate Infectious Diseases Clinical Research — Springfield, Massachusetts, United States
• Henry Ford Health System — Detroit, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Cooper University Hospital — Camden, New Jersey, United States
• New Jersey Medical School Adult Clinical Research Center — Newark, New Jersey, United States
• Cornell ID-CRU — New York, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Duke University — Durham, North Carolina, United States
• The Ohio State University Medical Center — Columbus, Ohio, United States
• Miami Valley Hospital — Dayton, Ohio, United States
• University of Tennessee College of Medicine — Chattanooga, Tennessee, United States
• Virginia Commonwealth University — Richmond, Virginia, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States
• Hospital Nacional Profesor Alejandro Posadas — El Palomar, Buenos Aires, Argentina
• Instituto Medico Platense — La Plata, Buenos Aires, Argentina
• Hospital Universitario Austral — Pilar, Buenos Aires, Argentina
• Hospital Profesor Bernardo Houssay — Vicente López, Buenos Aires, Argentina
• Sanatorio Britanico — Rosario, Santa Fe Province, Argentina
• CEMIC — Buenos Aires, Argentina
• Hospital General de Agudos JM Ramos Mejia — Buenos Aires, Argentina
• UCSD Antiviral Research Center — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.